Clinical Trial Update: Cholesterol-Lowering Effects of Policosanol [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating policosanol for lowering cholesterol was terminated; no efficacy or safety results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Combined Hyperlipidemia
• Hypercholesterolemia

Drugs mentioned

• Policosanol (Policosanol)

Snippet

Sponsor: Drug Commission of the German Medical Association | Conditions: Hypercholesterolemia, Combined Hyperlipidemia | Phase 3 | Status: TERMINATED